pharmaphorum23d
Boosted by new drugs, Boehringer shrugs off patent expiry
Despite the strong figures, Boehringer seems more focused on integrating its animal health acquisition, Merial, bought from Sanofi at the beginning of the year, into the company. Menne said there ...
Potential Opportunities In Pet Healthcare Stocks
While you may think of healthcare as only covering human health, animal and pet health is also a growing sector. Click to ...
US FDA approves Elanco's treatment for parasitic infections in dogs
The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect dogs against six parasitic ...
Morningstar9d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
Independent Online25d
World Rabies Day: Rabies can be prevented in humans and animals
Earlier this month, Boehringer Ingelheim, a leader in animal health, said it is stepping up its efforts to combat rabies in the country. It said that in response to the worst outbreak of rabies in ...
Pharmabiz7d
Boehringer Ingelheim & WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, pledged USD 5 million to advance access to quality healthcare services for ...
Hosted on MSN16d
US FDA approves Elanco's treatment for parasitic infections in dogs
(Reuters) -The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect ... paraciticide treatments for dogs include Boehringer Ingelheim's Nexgard Plus and ...
WOOD-TV8d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention.
BERLIN, Oct. 15, 2024 /PRNewswire/ -- Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to ...
Ottumwa Courier8d
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...